======= NAF1 ======= == Gene Information == * **Official Symbol**: N/AF1 * **Official Name**: nuclear assembly factor 1 ribonucleoprotein * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=92345|92345]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q96HR8|Q96HR8]] * **Interactions**: [[https://thebiogrid.org/search.php?search=NAF1&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20NAF1|Open PubMed]] * **OMIM**: [[https://omim.org/entry/617868|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: RNA-binding protein required for the maturation of box H/ACA snoRNPs complex and ribosome biogenesis. During assembly of the H/ACA snoRNPs complex, it associates with the complex and disappears during maturation of the complex and is replaced by NOLA1/GAR1 to yield mature H/ACA snoRNPs complex. Probably competes with NOLA1/GAR1 for binding with DKC1/NOLA4. {ECO:0000269|PubMed:16618814}. |Gar1| |box H/ACA snoRNP assembly| |snoRNA guided rRNA pseudouridine synthesis| |telomerase RNA stabilization| |telomerase holoenzyme complex assembly| |rRNA pseudouridine synthesis| |small nucleolar ribonucleoprotein complex| |small nucleolar ribonucleoprotein complex assembly| |positive regulation of telomerase RNA localization to Cajal body| |pseudouridine synthesis| |regulation of telomerase RNA localization to Cajal body| |telomerase RNA binding| |positive regulation of telomere maintenance via telomerase| |positive regulation of telomerase activity| |rRNA modification| |positive regulation of telomere maintenance via telomere lengthening| |RNA stabilization| |positive regulation of telomere maintenance| |regulation of telomerase activity| |regulation of telomere maintenance via telomerase| |negative regulation of RNA catabolic process| |regulation of telomere maintenance via telomere lengthening| |positive regulation of DNA biosynthetic process| |regulation of telomere maintenance| |regulation of DNA biosynthetic process| |RNA modification| |positive regulation of chromosome organization| |regulation of RNA stability| |positive regulation of DNA metabolic process| |rRNA processing| |rRNA metabolic process| |ribonucleoprotein complex assembly| |ribonucleoprotein complex subunit organization| |negative regulation of cellular catabolic process| |ribosome biogenesis| |negative regulation of catabolic process| |regulation of chromosome organization| |regulation of DNA metabolic process| |ncRNA processing| |ribonucleoprotein complex biogenesis| |ncRNA metabolic process| |posttranscriptional regulation of gene expression| |positive regulation of organelle organization| |positive regulation of transferase activity| |regulation of cellular catabolic process| |cellular protein-containing complex assembly| |RNA processing| |regulation of transferase activity| |regulation of catabolic process| |positive regulation of cellular component organization| |regulation of organelle organization| |negative regulation of RNA metabolic process| |RNA binding| |positive regulation of catalytic activity| |negative regulation of nucleobase-containing compound metabolic process| |protein-containing complex assembly| |RNA metabolic process| |positive regulation of molecular function| |protein-containing complex subunit organization| |positive regulation of nucleobase-containing compound metabolic process| |positive regulation of macromolecule biosynthetic process| |positive regulation of cellular biosynthetic process| |gene expression| |positive regulation of biosynthetic process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp1|5-Fluorouracil 2μM R00 exp1]]|-2.29| |[[:results:exp389|PF-06409577 20μM R07 exp389]]|-2.06| |[[:results:exp37|Wortmannin 0.5μM R00 exp37]]|-1.94| ^Gene^Correlation^ |[[:human genes:a:adsl|ADSL]]|0.504| |[[:human genes:z:zrsr2|ZRSR2]]|0.476| |[[:human genes:r:rpp21|RPP21]]|0.466| |[[:human genes:r:rnmt|RNMT]]|0.458| |[[:human genes:t:thg1l|THG1L]]|0.452| |[[:human genes:t:txnl4b|TXNL4B]]|0.449| |[[:human genes:r:rptor|RPTOR]]|0.431| |[[:human genes:u:utp23|UTP23]]|0.427| |[[:human genes:g:gmppb|GMPPB]]|0.426| |[[:human genes:h:hspd1|HSPD1]]|0.415| |[[:human genes:g:gtf3c3|GTF3C3]]|0.411| |[[:human genes:e:exoc4|EXOC4]]|0.408| |[[:human genes:y:yars|YARS]]|0.408| |[[:human genes:a:atp5o|ATP5O]]|0.406| |[[:human genes:r:rpe|RPE]]|0.404| Global Fraction of Cell Lines Where Essential: 27/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|1/1| |bile duct|1/28| |blood|0/28| |bone|0/26| |breast|1/33| |central nervous system|1/56| |cervix|0/4| |colorectal|0/17| |esophagus|2/13| |fibroblast|0/1| |gastric|0/16| |kidney|2/21| |liver|0/20| |lung|1/75| |lymphocyte|0/16| |ovary|1/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|4/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|2/22| |urinary tract|4/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 3913 * **Expression level (log2 read counts)**: 4.86 {{:chemogenomics:nalm6 dist.png?nolink |}}